Cargando…
Advances and Controversies With Checkpoint Inhibitors in Bladder Cancer
Immune checkpoint inhibitors have revolutionized the treatment of bladder urothelial cancers and have wide application in almost all disease states. Although several drugs have initially been shown to be beneficial in the second-line metastatic setting, there are still ongoing controversies and deba...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481722/ https://www.ncbi.nlm.nih.gov/pubmed/34602833 http://dx.doi.org/10.1177/11795549211044963 |